JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

Teladoc Inc

Suletud

SektorTervishoid

7.98 -2.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.82

Max

8.14

Põhinäitajad

By Trading Economics

Sissetulek

60M

-33M

Müük

2.5M

632M

Kasumimarginaal

-5.169

Töötajad

4,620

EBITDA

180M

59M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+19.04% upside

Turustatistika

By TradingEconomics

Turukapital

153M

1.6B

Eelmine avamishind

10.19

Eelmine sulgemishind

7.98

Uudiste sentiment

By Acuity

50%

50%

153 / 373 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Teladoc Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. nov 2025, 23:57 UTC

Tulu

Naver's Third-Quarter Earnings Rose on AI Push

4. nov 2025, 23:10 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4. nov 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. nov 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4. nov 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4. nov 2025, 23:30 UTC

Tulu

Itau Unibanco 3Q Net BRL33.7B >ITUB

4. nov 2025, 23:25 UTC

Tulu

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4. nov 2025, 23:25 UTC

Tulu

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4. nov 2025, 23:24 UTC

Tulu

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4. nov 2025, 23:23 UTC

Tulu

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4. nov 2025, 23:06 UTC

Tulu

Review & Preview: Tech Check -- Barrons.com

4. nov 2025, 22:52 UTC

Tulu

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4. nov 2025, 22:33 UTC

Tulu

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4. nov 2025, 22:29 UTC

Tulu

Ashland 4Q Adj EPS $1.08 >ASH

4. nov 2025, 22:29 UTC

Tulu

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4. nov 2025, 22:28 UTC

Tulu

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q Cont Ops EPS 73c >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q EPS 71c >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q Sales $478M >ASH

4. nov 2025, 22:23 UTC

Tulu

Ovintiv 3Q EPS 57c >OVV

4. nov 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4. nov 2025, 22:16 UTC

Tulu

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4. nov 2025, 22:14 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4. nov 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4. nov 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Consortium: Able to Finance a Deal With Available Liquidity

4. nov 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4. nov 2025, 22:11 UTC

Tulu

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4. nov 2025, 22:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4. nov 2025, 22:07 UTC

Tulu

Kinross Gold Raises Dividend to $0.035 >K.T

Võrdlus sarnastega

Hinnamuutus

Teladoc Inc Prognoos

Hinnasiht

By TipRanks

19.04% tõus

12 kuu keskmine prognoos

Keskmine 9.69 USD  19.04%

Kõrge 12 USD

Madal 8 USD

Põhineb 12 Wall Streeti analüütiku instrumendi Teladoc Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

12 ratings

3

Osta

9

Hoia

0

Müü

Tehniline skoor

By Trading Central

6.86 / 7.185Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

153 / 373 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Teladoc Inc

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
help-icon Live chat